Self-balancing exoskeleton to support rehabilitation after thoracic surgery
Official title: Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
Run by Wandercraft · NCT07220733 · Data updated 2026-11-12
This trial will test whether a wearable self-balancing exoskeleton (Atalante X) can help adults recovering from thoracic surgery stand and walk more safely in the ICU.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | Wandercraft Industry-sponsored |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | October 2025 |
| Main results expected | February 2026 |
| Study ends | February 2026 |
| Registry record updated | October 24, 2025 |
| Trial ID | NCT07220733 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) admitted to the Thoracic Surgical ICU after thoracic surgery who are debilitated (JH-HLM score ≤ 5) and who meet the device size and medical safety criteria are ideal candidates.
✕Probably not a fit
Patients with disqualifying conditions such as severe lower-extremity spasticity, recent unstable cardiac events, unhealed fractures, severe osteoporosis, significant skin breakdown at contact sites, or those outside the device height/weight limits are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-arm pilot conducted in the Thoracic Surgical ICU at Brigham and Women's Hospital using the Atalante X self-balancing robotic exoskeleton. Eligible adult patients who are debilitated after thoracic surgery (JH-HLM ≤ 5) will receive individualized exoskeleton sessions up to 2–3 times per week for a maximum of two weeks, with progressive standing and walking as tolerated. The study will focus on safety and feasibility outcomes, monitoring vital signs, device tolerability, and any adverse events while documenting mobility gains and staff assistance requirements. Results will inform whether this device can be integrated into early ICU rehabilitation workflows.
Why it matters
Potential benefit: If successful, this approach could help patients stand and walk earlier after thoracic surgery, reduce complications related to immobility, and lessen the physical burden on staff.
How similar studies have gone: Previous clinical work with the Atalante X in spinal cord injury and post-stroke populations demonstrated safety and feasibility with mobility gains, but its use in the immediate postoperative ICU setting is a novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Above age of 18 years old, * Having undergone thoracic surgery that necessitated admission in the TSICU. * Debilitated as defined as a JH-HLM score of 5 or less Exclusion Criteria: * Height \< 6'3 feet or weight \> 220 lbs restrictions * Severe muscular spasticity of the lower extremities (Modified Ashworth Scale Grade 3 higher). * Current fractures or incomplete bone junctions in the spine, pelvis, and/or lower extremities * Osteoporosis or lower bone mineral density -3.5, and history(ies) of osteoporotic fracture(s). * Skin disorders including Stage I pressure injuries at the hip, lower limbs, and Exoskeleton contact areas, according to the National and European Pressure Ulcer Classification System (NPUAP-EPUAP). * Severe arthritis, acute arthritis, or synovitis after total or partial lower limb joint replacement. * Myocardial infarction or angina or ischemic heart disease within the last 6 months. * Uncorrectable leg length discrepancy over 2 cm when using additional correction tools. * III-IV spine scoliotic deformity. * Amputations and lower limb prostheses. * Pregnancy * Adults who lack the capacity to provide informed consent * Cardiovascular instability as indicated by: * Presence of unstable ventricular or atrial arrhythmias * HR \< 40 or HR \> 140 * Lactate \> 4.0 mmol/L * On moderate-high dose vasopressors/inotropes * Currently on VA ECMO * Respiratory instability as indicated by: * FiO2 \> 0.6 * PEEP \> 12 cm H2O * RR \> 35 bpm * Currently on VV-ECMO * Unable to follow commands * Has bed rest orders
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Raghu Seethala
- Email: RSEETHALA@BWH.HARVARD.EDU
- Phone: 617-525-3150
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.